Role of Multidrug Resistance P-glycoproteins in Cholesterol Biosynthesis
Open Access
- 1 February 1996
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (5), 2634-2640
- https://doi.org/10.1074/jbc.271.5.2634
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association and the Primary Children's Research Foundation of Utah
This publication has 29 references indexed in Scilit:
- Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women After 5 Years of TreatmentJNCI Journal of the National Cancer Institute, 1994
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseaseCell, 1993
- MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transportersNature, 1990
- Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiographyJournal of the American College of Cardiology, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Sequence of mdr3 cDNA encoding a human P-glycoproteinGene, 1988
- Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesisThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.Journal of Clinical Investigation, 1988
- Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questionsAmerican Heart Journal, 1987
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986